Reflecting on this year's PHA conference in Dallas, columnist Mike Naple writes that connecting with community can be the best medicine.

Most PAH patients who completed one year in a CS1 expanded access program had stable or improved clinical measures.

At the Pulmonary Hypertension Association’s (PHA) biannual conference, it is easy to feel like you should be able to do more. There are sessions to attend, people to meet, dinners to join, and ...

Blocking a signaling pathway in certain white blood cells may prevent clots from obstructing blood flow and causing CTEPH, per a new study.

Nine members of the pulmonary hypertension (PH) community have received awards for their support of the Pulmonary ...

Subtle liver problems may contribute to the development of pulmonary arterial hypertension (PAH), suggesting complex communication between the lungs and liver along a so-called lung-liver axis, ...

Corsair Pharma‘s experimental skin-worn patch designed to deliver treprostinil, an approved treatment for pulmonary arterial hypertension (PAH), appears to be working as intended, according to newly ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google A new partnership aims to incorporate more patient perspectives ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google When I was 12, an infection related to my central line landed me ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit “During Q1 2026, we made meaningful progress advancing [TX45] across key clinical milestones, ...